These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22550726)

  • 21. Balancing the cyclooxygenase portfolio.
    Armstrong PW
    CMAJ; 2006 May; 174(11):1581-2. PubMed ID: 16717266
    [No Abstract]   [Full Text] [Related]  

  • 22. Appropriate use of NSAIDs: considering cardiovascular risk in the elderly.
    Stillman MJ; Stillman MT
    Geriatrics; 2007 Mar; 62(3):16-21. PubMed ID: 17346094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
    Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
    J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
    Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
    Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. General practitioners' opinions on the intake of painkillers among patients.
    Latalski M; Skórzyńska H; Pacian A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):407-12. PubMed ID: 12898952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Overestimated].
    Höer A; Häussler B
    Med Klin (Munich); 2006 Aug; 101(8):676-7; author reply 678-9. PubMed ID: 17051671
    [No Abstract]   [Full Text] [Related]  

  • 27. NSAIDS and the risk of myocardial infarction: do they help or harm?
    Bhatt DL
    Eur Heart J; 2006 Jul; 27(14):1635-6. PubMed ID: 16782714
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.
    Andersohn F; Suissa S; Garbe E
    Circulation; 2006 Apr; 113(16):1950-7. PubMed ID: 16618816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.
    van der Linden MW; van der Bij S; Welsing P; Kuipers EJ; Herings RM
    Ann Rheum Dis; 2009 May; 68(5):668-73. PubMed ID: 18495734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
    van Staa TP; Rietbrock S; Setakis E; Leufkens HG
    J Intern Med; 2008 Nov; 264(5):481-92. PubMed ID: 18624902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population.
    García Rodríguez LA; González-Pérez A
    BMC Med; 2005 Nov; 3():17. PubMed ID: 16316472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The COX-2 controversy continues ...but NSAIDs are still in the lead. New studies shed light on risks associated with popular arthritis painkillers.
    Health News; 2006 Aug; 12(8):3-4. PubMed ID: 16913025
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury.
    Lafrance JP; Miller DR
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):923-31. PubMed ID: 19585463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More warnings about common pain relievers.
    Health News; 2005 Sep; 11(9):4. PubMed ID: 16211679
    [No Abstract]   [Full Text] [Related]  

  • 35. [Do selective COX-2-inhibitors increase the risk of myocardial infarction?].
    Otterstad JE
    Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3434-5. PubMed ID: 14713991
    [No Abstract]   [Full Text] [Related]  

  • 36. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Non steroidal anti-inflammatory drugs (NSAIDs) - balancing gastrointestinal complications and the cardiovascular risk].
    Kandulski A; Venerito M; Malfertheiner P
    Dtsch Med Wochenschr; 2009 Aug; 134(33):1635-40; quiz 1641-4. PubMed ID: 19650027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular complications of non-steroidal anti-inflammatory drugs.
    Fosslien E
    Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New epidemiologic data show: conventional NSAIDs need individual benefit-risk evaluation].
    MMW Fortschr Med; 2005 Nov; 147(47):62-3. PubMed ID: 16370198
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prescription of non-steroidal anti-inflammatory drugs].
    Bannwarth B
    Bull Acad Natl Med; 1998; 182(7):1431-7; discussion 1437-8. PubMed ID: 9916337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.